AKTX CIK: 1541157

Akari Therapeutics Plc

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
0.00
FY23:
0
FY24:
0
FY25:
0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−17.2
FY22:
−23.1
FY23:
−16.8
FY24:
−21.6
FY25:
−17.3
(positive)
Change from FY21 to FY22
millions USD
FY21:
−17.0
FY22:
−28.5
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−17.4
FY22:
−0.02
FY23:
−10.0
FY24:
−19.8
FY25:
−18.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
−17.4
FY22:
−17.7
FY23:
−10.0
FY24:
−19.8
FY25:
−17.3

All amounts in millions USD Data sources:SEC EDGARTwelve Data